(Q41663791)

English

Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials

scientific article published on October 1997

Statements

Large scale manufacturing of TXU(anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials (English)
1 October 1997
275-302

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit